The Relationship Between Healthy Lifestyle Behaviors, Physical Activity and Blood Tests in Pregnancy
1 other identifier
observational
649
1 country
2
Brief Summary
Pregnancy is a significant phase in women's lives, marked by psychological, biological, and emotional changes. It lasts for approximately nine months and is divided into three trimesters. Identifying risk factors such as maternal age, gestational age, ethnicity, and lifestyle habits is crucial for managing pregnancy effectively. Anxiety, depression, and stress can significantly impact pregnancy-related responsibilities and overall well-being, making collaboration with a multidisciplinary healthcare team essential. Physical activity during pregnancy offers numerous benefits, including better physical fitness, improved psychological health, weight management, and reduced risk of gestational diabetes. However, studies show that many women are not sufficiently active, particularly in the first trimester, where activity levels tend to be lower. Regular monitoring of thyroid function (TSH levels) and liver enzymes (ALT, AST) is essential to avoid complications, as pregnancy can affect thyroid function and liver health. Additionally, monitoring hemoglobin and hematocrit levels is necessary to manage pregnancy anemia. The proposed study aims to evaluate healthy lifestyle behaviors, physical activity, and biochemical markers among pregnant women in the first trimester, using various questionnaires and laboratory tests. This study will provide valuable insights into maternal health and guide clinical practices during early pregnancy to reduce complications and enhance overall outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2024
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 15, 2024
CompletedFirst Submitted
Initial submission to the registry
November 27, 2024
CompletedFirst Posted
Study publicly available on registry
December 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedJuly 14, 2025
November 1, 2024
6 months
November 27, 2024
July 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biochemistry result
LOWER AND UPPER LIMIT VALUES FOR SERUM TSH; 0.1 - 2.5 mU/L for the first trimester, 0.2 - 3.0 mU/L for the second trimester and 0.3 - 3.0 mU/L for the third trimester. Reference values should be between AST: 5-40 U/L and ALT: 7-56 U/L.
1 day
Secondary Outcomes (2)
Healthy Lifestyle Behaviors Scale During Pregnancy
1 day (A one-time survey when the patient first arrives)
Pregnancy Physical Activity Questionnaire
1 day (A one-time survey when the patient first arrives)
Eligibility Criteria
The study will be conducted between 15.08.2024 and 15.08.2025. The research will be conducted in Kayseri City Hospital Gynecology and Obstetrics Polyclinic and will be conducted as a single center.
You may qualify if:
- Singleton pregnancy
- Maternal age between 18 and 40 years
- In the first trimester of pregnancy
- Literate and capable of understanding written materials
You may not qualify if:
- Multiple pregnancies
- Non-natural pregnancies
- Family history of thyroid dysfunction
- Presence of thyroid dysfunction and/or autoimmunity
- Clinical diagnosis of Diabetes Mellitus
- Clinical diagnosis of liver disease
- Presence of any physical or mental disability
- Chronic endocrine, autoimmune, or metabolic diseases
- Voluntary withdrawal from the study
- Inability to complete the questionnaires included in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Inonu Universitylead
- Kayseri City Hospitalcollaborator
Study Sites (2)
Kayseri City Hospital
Kayseri, Turkey, 38030, Turkey (Türkiye)
Kayseri City Hospital
Kayseri, 30080, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
November 27, 2024
First Posted
December 13, 2024
Study Start
August 15, 2024
Primary Completion
February 15, 2025
Study Completion
April 1, 2025
Last Updated
July 14, 2025
Record last verified: 2024-11